Anavex Life Sciences Corp.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Dec 2010 | $-1.1M | $-1.1M | — | $187.8K |
| Mar 2011 | $-588.9K | $-588.9K | — | $668.5K |
| Jun 2011 | $-1.2M | $-1.2M | — | $159.2K |
| Sep 2011 | $-922.6K | $-922.6K | — | $257.7K |
| Dec 2011 | $-1.1M | $-1.1M | — | $123.3K |
| Mar 2012 | $-114.2K | $-114.2K | — | $80.1K |
| Jun 2012 | $-238.7K | $-238.7K | — | $98.8K |
| Sep 2012 | $-251.9K | $-251.9K | — | $0 |
| Dec 2012 | $-131.6K | $-131.6K | — | $0 |
| Mar 2013 | $-129.3K | $-129.3K | — | $0 |
| Jun 2013 | $-32.2K | $-32.2K | — | $0 |
| Sep 2013 | $-484.5K | $-484.5K | — | $1.0M |
| Dec 2013 | $-435.0K | $-435.0K | — | $0 |
| Mar 2014 | $-347.5K | $-347.5K | — | $0 |
| Jun 2014 | $-960.0K | $-960.0K | — | $9.6K |
| Sep 2014 | $-916.9K | $-916.9K | — | $628.3K |
| Dec 2014 | $-693.1K | $-693.1K | — | $15.4K |
| Mar 2015 | $-670.3K | $-670.3K | — | $16.2K |
| Jun 2015 | $-1.4M | $-1.4M | — | $233.9K |
| Sep 2015 | $-1.4M | $-1.4M | — | $1.4M |
| Dec 2015 | $-3.2M | $-3.2M | — | $826.0K |
| Mar 2016 | $-1.9M | $-1.9M | — | $222.7K |
| Jun 2016 | $-2.2M | $-2.2M | — | $228.3K |
| Sep 2016 | $-1.9M | $-1.9M | — | $3.8M |
| Dec 2016 | $-3.2M | $-3.2M | — | $889.3K |
| Mar 2017 | $-697.7K | $-697.7K | — | $968.9K |
| Jun 2017 | $-3.0M | $-3.0M | — | $1.2M |
| Sep 2017 | $-2.2M | $-2.2M | — | $1.1M |
| Dec 2017 | $-3.6M | $-3.6M | — | $1.1M |
| Mar 2018 | $-2.8M | $-2.8M | — | $1.2M |
| Jun 2018 | $-2.1M | $-2.1M | — | $1.7M |
| Sep 2018 | $-4.1M | $-4.1M | — | $1.5M |
| Dec 2018 | $-4.2M | $-4.2M | — | $2.1M |
| Mar 2019 | $-4.3M | $-4.3M | — | $1.9M |
| Jun 2019 | $-7.5M | $-7.5M | — | $1.2M |
| Sep 2019 | $-2.5M | $-2.5M | — | $1.2M |
| Dec 2019 | $-5.7M | $-5.7M | — | $1.3M |
| Mar 2020 | $-5.3M | $-5.3M | — | $1.7M |
| Jun 2020 | $-4.0M | $-4.0M | — | $1.3M |
| Sep 2020 | $-6.3M | $-6.3M | — | $660.6K |
| Dec 2020 | $-7.9M | $-7.9M | — | $939.3K |
| Mar 2021 | $-7.3M | $-7.3M | — | $1.8M |
| Jun 2021 | $-7.5M | $-7.5M | — | $2.3M |
| Sep 2021 | $-7.7M | $-7.7M | — | $3.2M |
| Dec 2021 | $-3.5M | $-3.5M | — | $3.9M |
| Mar 2022 | $-9.6M | $-9.6M | — | $4.4M |
| Jun 2022 | $-7.1M | $-7.1M | — | $4.0M |
| Sep 2022 | $-4.0M | $-4.0M | — | $6.0M |
| Dec 2022 | $-5.8M | $-5.8M | — | $5.3M |
| Mar 2023 | $-8.5M | $-8.5M | — | $4.0M |
| Jun 2023 | $-7.7M | $-7.7M | — | $3.9M |
| Sep 2023 | $-5.8M | $-5.8M | — | $3.2M |
| Dec 2023 | $-7.3M | $-7.3M | — | $2.3M |
| Mar 2024 | $-11.7M | $-11.7M | — | $2.7M |
| Jun 2024 | $-5.2M | $-5.2M | — | $2.5M |
| Sep 2024 | $-6.7M | $-6.7M | — | $2.0M |
| Dec 2024 | $-12.1M | $-12.1M | — | $2.1M |
| Mar 2025 | $-5.9M | $-5.9M | — | $1.4M |
| Jun 2025 | $-12.5M | $-12.5M | — | $4.3M |
| Sep 2025 | $-8.6M | $-8.6M | — | $3.7M |
| Dec 2025 | $-7.2M | $-7.2M | — | $1.1M |
| Mar 2026 | $-4.4M | $-4.4M | — | $314.0K |
| Jun 2026 | $-9.1M | $-9.1M | — | $-17.1M |